Henry Ford Health System ( Site 0002)

Detroit, Michigan 48202

0 studies enrolling now · 2 studies all time

What they study most

Neoplasms

Studies at this site

• Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) — Completed
• A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) — Completed